木瓜直播

Crystal Phend

Crystal Phend

Authors >

Crystal Phend

Crystal Phend is a contributing editor with 木瓜直播, where she's been covering medical news of all stripes since 2006.

Connect:

email image

Latest from Crystal Phend

Illustration of a hospital bed, IV, and a red medical plus icon in a circle over a heart with cardiomyopathy

Inpatient Management of Cardiomyopathy

While tackling congestion is key, the admission is an opportunity to redirect the clinical course

Illustration of a cell phone with a finger pressing a red medical plus icon over a heart with cardiomyopathy

For Your Cardiomyopathy Patients: Knowing When to Seek Medical Care

Warning signs and signals that you need to seek prompt medical attention

AHA over a computer rendering of the heart.

Clinical Challenges: Treating Recovered Dilated Cardiomyopathy

Optimal strategies aren't well established, but continuing medications has a clear mandate

A package of Pfizer Paxlovid, a treatment for COVID-19.

Paxlovid Vindicated for Younger COVID Patients

CDC study supports similar benefit in those under 50 as in seniors

AHA over a computer rendering of the heart.

Anticoagulation Again Flops for Outpatient COVID-19

Largest-yet RCT shows no benefit for non-hospitalized symptomatic patients despite elevated risk

AHA over a computer rendering of the heart.

Moving Fast on HF Drugs After Acute Hospitalization Holds Big Outcome Benefit

Randomized trial shows advantages across heart failure spectrum

AHA over a computer rendering of the heart.

Bivalirudin Crowned as Better Anticoagulant for Primary PCI in STEMI

BRIGHT-4 trial hands the drug a "clear, unambiguous win" against heparin

AHA over a computer rendering of the heart.

Early Invasive Strategy for Stable CAD Holds No Long-Term Survival Advantage

Extended follow-up of ISCHEMIA trial weighs in on mortality

AHA over a heart

Definitive Answer on Steroids for Infant Heart Surgery Falls Short

STRESS trial misses primary endpoint but secondary benefits are suggestive

AHA over a heart

Diuretics on Par in Head-to-Head Comparison for Hypertension

But a surprise signal emerges for one group in pragmatic trial

鈥�

24

鈥�